These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 28658153

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis.
    Hu Y, Shen J, Liu R, Feng Z, Zhang C, Ling L, Chen L.
    Int J Biol Markers; 2018 Nov; 33(4):372-378. PubMed ID: 30282502
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
    Zhao S, Qiu Z, He J, Li L, Li W.
    Int J Clin Exp Pathol; 2014 Nov; 7(10):6694-704. PubMed ID: 25400749
    [Abstract] [Full Text] [Related]

  • 26. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Zhu L, Yu H, Liu SY, Xiao XS, Dong WH, Chen YN, Xu W, Zhu T.
    PLoS One; 2015 Nov; 10(4):e0124230. PubMed ID: 25905787
    [Abstract] [Full Text] [Related]

  • 27. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Zhan B, Lu D, Luo P, Wang B.
    Clin Lab; 2016 Nov 01; 62(11):2203-2211. PubMed ID: 28164670
    [Abstract] [Full Text] [Related]

  • 28. Assessment of clinicopathological and prognostic relevance of BMI-1 in patients with colorectal cancer: A meta-analysis.
    Pourjafar M, Samadi P, Karami M, Najafi R.
    Biotechnol Appl Biochem; 2021 Dec 01; 68(6):1313-1322. PubMed ID: 33086431
    [Abstract] [Full Text] [Related]

  • 29. Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis.
    Chen S, Huang L, Sun K, Wu D, Li M, Li M, Zhong B, Chen M, Zhang S.
    PLoS One; 2015 Dec 01; 10(5):e0125480. PubMed ID: 25974088
    [Abstract] [Full Text] [Related]

  • 30. Prognostic role of hypoxic inducible factor expression in non-small cell lung cancer: a meta-analysis.
    Li C, Lu HJ, Na FF, Deng L, Xue JX, Wang JW, Wang YQ, Li QL, Lu Y.
    Asian Pac J Cancer Prev; 2013 Dec 01; 14(6):3607-12. PubMed ID: 23886153
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L, Li Z, Shao X, Yang B, Feng J, Xu L, Teng Y.
    Pathol Res Pract; 2019 Sep 01; 215(9):152449. PubMed ID: 31378453
    [Abstract] [Full Text] [Related]

  • 32. Prognostic role of high Bmi-1 expression in Asian and Caucasian patients with solid tumors: a meta-analysis.
    Shao Y, Geng Y, Gu W, Ning Z, Jiang J, Pei H.
    Biomed Pharmacother; 2014 Oct 01; 68(8):969-77. PubMed ID: 25458792
    [Abstract] [Full Text] [Related]

  • 33. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
    Huber GF, Albinger-Hegyi A, Soltermann A, Roessle M, Graf N, Haerle SK, Holzmann D, Moch H, Hegyi I.
    Cancer; 2011 Oct 15; 117(20):4659-70. PubMed ID: 21448927
    [Abstract] [Full Text] [Related]

  • 34. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y, Wu K, Shi L, Xiang F, Tao K, Wang G.
    PLoS One; 2016 Oct 15; 11(11):e0166230. PubMed ID: 27824926
    [Abstract] [Full Text] [Related]

  • 35. Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
    Tan Z, Yang C, Zhang X, Zheng P, Shen W.
    Oncotarget; 2017 Sep 22; 8(37):60954-60961. PubMed ID: 28977837
    [Abstract] [Full Text] [Related]

  • 36. Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: A meta-analysis.
    Chen B, Li H, Liu C, Xiang X, Wang S, Wu A, Shen Y, Li G.
    PLoS One; 2020 Sep 22; 15(11):e0242173. PubMed ID: 33170901
    [Abstract] [Full Text] [Related]

  • 37. The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis.
    Zhao J, Shi X, Wang T, Ying C, He S, Chen Y.
    Cell Physiol Biochem; 2017 Sep 22; 43(2):697-704. PubMed ID: 28946136
    [Abstract] [Full Text] [Related]

  • 38. Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: A meta-analysis.
    Cao LL, Song X, Pei L, Liu L, Wang H, Jia M.
    Medicine (Baltimore); 2017 Aug 22; 96(31):e7663. PubMed ID: 28767587
    [Abstract] [Full Text] [Related]

  • 39. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
    Tong M, Wang J, Jiang N, Pan H, Li D.
    PLoS One; 2017 Aug 22; 12(8):e0182282. PubMed ID: 28797050
    [Abstract] [Full Text] [Related]

  • 40. Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis.
    Jin Y, Sun Y, Shi X, Zhao J, Shi L, Yu X.
    J Cancer Res Ther; 2014 Nov 22; 10 Suppl():C160-6. PubMed ID: 25450276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.